Gil Johnson, MD
Adult Medicine · Conway, ARNPI 1356563241
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Novo Nordisk at 25.2% of the total.
Across 31 payments — averaging $31.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$248
- Lilly USA, LLC$153
- Pfizer$102
- Boehringer Ingelheim$90
- GSK$86
- Phadia US Inc.$86
- plus $219 from 7 others
What the payments were for
- Food & beverage$984100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $248 |
| Lilly USA, LLC | 7 | $153 |
| Pfizer | 2 | $102 |
| Boehringer Ingelheim | 2 | $90 |
| GSK | 1 | $86 |
| Phadia US Inc. | 1 | $86 |
| Otsuka America Pharmaceutical, Inc. | 1 | $65 |
| Amarin Pharma, Inc. | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| AstraZeneca | 1 | $27 |
| Abbott | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $14 |
How this compares
Too few adult medicine providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 49 | $59,949 |
| EliquisApixaban | 67 | $45,065 |
| TrulicityDulaglutide | 19 | $33,927 |
| JanuviaSitagliptin Phosphate | 30 | $31,654 |
| JardianceEmpagliflozin | 19 | $16,172 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $7,284 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 11 | $6,234 |
| Incruse ElliptaUmeclidinium Bromide | 11 | $3,568 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $3,157 |
| SynthroidLevothyroxine Sodium | 42 | $2,523 |
| Ezetimibe-SimvastatinEzetimibe/Simvastatin | 16 | $2,409 |
| Novolin 70-30Insulin Nph Hum/Reg Insulin Hm | 24 | $2,393 |
| Febuxostat | 19 | $1,814 |
| Irbesartan | 84 | $1,599 |
| Atorvastatin Calcium | 241 | $1,470 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $248 | $59,94949 claims |
| PfizerEliquis | $102 | $45,06567 claims |
| Lilly USA, LLCTrulicity | $153 | $33,92719 claims |
| Boehringer IngelheimJardiance | $90 | $16,17219 claims |
| GSKIncruse Ellipta | $86 | $3,56811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few adult medicine providers in Arkansason file to place this against a meaningful peer group, so we don't.
Other adult medicine in Conway
- Vicki StancilConway$16
- Jheanelle DawkinsSherwood$4K
- Barton ParishHot Springs$3K
- Jessica SearsFayetteville$2K
- Charles CarttarLittle Rock$749
- Diata HartLittle Rock$528
- Donna BeallisSpringdale$219
- Muhammad Omar KhanFort Smith$125
- Johnny PaineSearcy$118
- Valerie ShelbyFort Smith$98
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.